Baptist Health Herbert Wertheim Cancer Institute is pleased to welcome Michael F. Walsh, M.D., a board-certified medical geneticist specializing in hereditary cancer predisposition. Dr. Walsh will serve as deputy director of Baptist Health Cancer Care and chief of the Herbert Wertheim Center for Cancer Prevention.
Before joining Baptist Health, Dr. Walsh was medical director of global development and clinical sciences in hematology at Regeneron Pharmaceuticals, where his work included clinical trials focused on cancer-associated thrombosis. Previously, he spent nearly a decade at Memorial Sloan Kettering Cancer Center (MSKCC), where he advanced from assistant member to associate member working on cancer prevention in adults and children. He also served as an associate professor at Weill Cornell Medical College (WCMC) and associate program director of the MSKCC/WCMC Medical Genetics Fellowship Program.
Dr. Walsh earned his medical degree at University College Dublin. He completed pediatric and medical genetics training at Johns Hopkins Hospital in Baltimore and a pediatric hematology-oncology fellowship at St. Jude Children’s Research Hospital in Memphis, Tennessee.
